Remarkably, we observed that patients bearing a tumor with low NKX3-2 together with high MAP1LC3B levels (indicative of active autophagy) display a favorable clinical outcome (Figure 7B), reinforcing the view that this signature may have translational relevance for ovarian cancer. This evidence concerns the gene NKX3-2 and ovarian cancer.